Clinical Trials Logo

Clinical Trial Summary

The primary purpose of this study is to evaluate the efficacy and safety of lubiprostone administration in patients with opioid-induced bowel dysfunction (OBD).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00597428
Study type Interventional
Source Mallinckrodt
Contact
Status Completed
Phase Phase 3
Start date August 2007
Completion date March 2009

See also
  Status Clinical Trial Phase
Recruiting NCT06334198 - The Effect of Naldemedine on Opioid-induced Bowel Dysfunction Phase 2
Completed NCT01298219 - Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL) Phase 3
Completed NCT00620061 - Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone Phase 3
Completed NCT00595946 - Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone Phase 3
Completed NCT06385561 - The Influence of Tramadol on Opioid-induced Bowel Dysfunction Phase 2
Recruiting NCT04876508 - The Efficacy of Acupressure in Managing Opioid-induced Constipation N/A